Back

Lipoprotein(a) levels above 70 mg/dL are an independent predictor for long-term major adverse cardiovascular events in patients with premature (<40 years) acute coronary syndrome

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Loukianos Rallidis

Attikon University Hospital, Athens (Greece)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Swieszkowski (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor J. Costabel (Buenos Aires, AR)
Abstract
Presentation thumbnail
Doctor H. Wada (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of lipoprotein A on long-term outcomes in acute coronary syndrome: a retrospective cohort analysis
19 May 2025
thumbnail
Congress Presentation
Premature coronary artery disease in all-comers undergoing first PCI
25 August 2023
thumbnail
Congress Presentation
Lp(a) measurement in younger patients following ST-elevation myocardial infarction: insights from a contemporary regional registry.
31 August 2025
thumbnail
Congress Presentation
Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources